Announcements Trials
Browse Landscape

Phase

Phase NA 18Phase 3 3Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Breast Neoplasms 5Prostatic Neoplasms 4Multiple Myeloma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Non-Hodgkin 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Mycosis Fungoides 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Leukemia, Hairy Cell 3Leukemia 3Hodgkin Disease 3Head and Neck Neoplasms 3Brain Neoplasms 3Blast Crisis 3Melanoma 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

Modafinil 9Methylphenidate 4Saline Solution 3regorafenib 2Sugars 2Physical Therapy Modalities 2Exercise 2Dexamethasone 2reparixin 1ofatumumab 1epoetin beta 1eicosapentaenoic acid ethyl ester 1eicosapentaenoic acid ethanolamide 1clazakizumab 1caffeine, sodium benzoate drug combination 1Yoga 1Walking 1Waiting Lists 1Vinorelbine 1Urinalysis 1Therapeutics 1Thalidomide 1Testosterone 1Sodium Chloride 1Proton Pump Inhibitors 1Patient Reported Outcome Measures 1Megestrol Acetate 1Lenalidomide 1Lactose 1Infliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fatigue × Therapeutics × Clear all
NCT01097317 2011-08-08

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
52 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡